Arrowhead Pharmaceuticals Inc (ARWR)
NASDAQ
Quarter End | Déc 2022 | Mar 2023 | Juin 2023 | Sept 2023 | Déc 2023 | Mar 2024 | Juin 2024 | Sept 2024 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Revenu total | 62,55M | 146,27M | 15,83M | 16,1M | 3,55M | 0 | 0 | 0 |
Revenu d'exploitation | -42,13M | 48,17M | -102,7M | -108,33M | -136,55M | -126,19M | -176,14M | -162,2M |
Revenu avant impôt | -41,79M | 47,68M | -103,38M | -108,99M | -138,69M | -127M | -173,98M | -172,8M |
Revenu net | -41,33M | 48,68M | -102,95M | -109,68M | -132,86M | -125,3M | -170,79M | -170,54M |
Dividendes privilégiés | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Résultat de base par action | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
EBIT | -41,63M | 48,17M | -102,4M | -107,61M | -136,12M | -126M | -175,38M | -163,95M |
EBITDA | -39,45M | 50,83M | -99,43M | -104,47M | -132,28M | -121,67M | -171,36M | -157,18M |
Fin d'année 30 Septembre 2024 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Revenu total | 31,41M | 16,14M | 168,8M | 87,99M | 138,29M | 243,23M | 240,74M | 3,55M |
Revenu d'exploitation | -37M | -55,94M | 61,19M | -93,16M | -149,04M | -178,51M | -205M | -601,08M |
Revenu avant impôt | -34,38M | -54,45M | 68,15M | -84,55M | -140,85M | -172,71M | -206,49M | -612,46M |
Revenu net | -34,38M | -54,45M | 67,98M | -84,55M | -140,85M | -176,06M | -205,28M | -599,49M |
Dividendes privilégiés | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Résultat de base par action | -0.46 | -0.615 | 0.712 | -0.826 | -1.35 | -1.661 | -1.915 | -4.822 |
EBIT | -35,68M | -55,93M | 61,19M | -93,74M | -146,97M | -177,74M | -203,46M | -602,83M |
EBITDA | -32,31M | -51,24M | 65,63M | -87,22M | -140,77M | -168,09M | -192,51M | -582,49M |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales